Precision Medicine Europe 2027
30 November - 01 December 2027
Congress Centre Basel, Switzerland
Congress Centre Basel, Switzerland
BREAKING DOWN SILOS. CONNECTING EXPERTISE. ACCELERATING PATIENT IMPACT.
Precision Medicine Europe, formerly Biomarkers, CDx & Precision Medicine Europe and NextGen Omics, Tech & Data, brings together the scientific disciplines, technologies and decision-makers advancing drug development, clinical research, diagnostics and patient care.
30 November - 01 December 2027
Congress Centre Basel, Basel, Switzerland
Featured Speakers from Biomarkers, CDx & Precision Medicine 2026
Adisa Trnjanin
Co-Founder & Co-Head,
ZHAW Life Sciences
Aditi Deshpande
Director, Biology,
Bioage labs
Alberto Valdeolivas Urbelz
Principal Scientist,
Roche
Amela Jusic
Translational Research Lead,
Quant Biomarkers
Andrew Nelson
Senior Director,
Real Chemistry, Integrated Intelligence
Anissa Fries
Lead Scientist, Flow Cytometry,
Labcorp
Antonino Carbone
Chairman of the Department of Pathology,
Centro di Riferimento Oncologico di Aviano
Arijit Patra
Senior Principal Scientist,
Ucb
Bernhard Polzer
Head of Cellular and Molecular Diagnostics,
Fraunhofer Institute
Bogdan Munteanu
Lab Head Global Imaging Mass Spectrometry Biomarker Discovery Platform (DMPK),
Sanofi
Carsten Krantz
Associate Director,
Novartis
Catherine Gilbert
Field Application Scientist,
Seer
Céline Pallaud
Precision Medicine Strategy Head,
Novartis
Celine Vandamme
Director, Scientific Business Development,
CellCarta
Clare Killick-Cole
Director of Business Development,
Genomics
Daniel Truhn
Professor of AI in Medicine,
RWTH Aachen University
David Klug
Professor of Chemical Biophysics, Department of Chemistry,
Imperial College London
David Latto
Associate Product Specialist Director ,
IQVIA Laboratories
Diego Saldana Miranda
Associate Director and Senior Data Scientist,
Novartis
Emmanouil Karteris
Professor in Biomedical Sciences,
Brunel University of London
Enchi Liu
Vice President & Head Experimental Medicine,
Lundbeck
Eric Letouzé
Head of Single Cell,
One Biosciences
Eshita Mutt
Bioinformatics Support Scientist,
Illumina
Eshita Mutt,
Global Head of Scientific Strategies,
StratifAI
Espen Walker
Head of Global Medical Diagnostics,
AstraZeneca
Federico Pratesi
Senior Multiomics Sales Specialist,
Illumina
Florian Langer
Sales & Applications Manager,
Histomography GmbH
Gavin Gordon
SVP, Precision Medicine & Strategic Alliances,
Singular Genomics
Georgia Cresswell
Research Services Business Development Manager,
Patholytix
Guillaume Cettou
Executive Director Diagnostics,
GSK
Heleen Verlinden
Senior Director,
Muna Therapeutics (K5)
Helene Fachim
Clinical Research Manager,
Cure Parkinson's
Inês Santarino
Business Development Manager,
Cyentia Biosource
Isabella Gashaw
Head of Experimental Sciences CRM,
Boehringer Ingelheim
Jacek Lukawy
Innovation Program Director, Translational Medicine Clinical Sciences and Innovation/NIBR,
Novartis
Jan Lukas Robertus
Honorary Associate Professor, Imperial College London and Head of Pathology Department,
Royal Brompton & Harefield NHS Foundation Trust
Janne Martikainen
Professor,
University of Eastern Finland
Jennifer Tucker
Global Head of Regulatory Affairs, Pathology Lab,
Roche Tissue Diagnostics
Jessica Apulei
Scientific Liaison Manager - EMEA,
Hologic Diagenode
JM Bokhorst
AI Research,
IndicaLabs
Johan Lundin
Research Director,
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Johan Luthman
Executive Vice President & Head R&D ,
Lundbeck
Julia Jabs
Head of Biomarker Lab Histology,
Merck Healthcare KGaA
Karthikeyan Devaraju
Sr Scientist,
Cerba Research
Kathrin Heinzmann
Senior Biomarker Scientist,
Cancer Research UK
Kathrin Schlueter
Medical Affairs Manager,
BD
-adf95f.jpg?length=600&name=23517ff4-aef9-409c-b936-18a411b8670a-2-11764368speaker_photo-PLC25722-HR-(fotograaf-Paul-Lagro)-adf95f.jpg)
Katrien Grünberg
Professor of Pathology and Head of Pathology Department,
Radboud UMC
Kedar Natarajan
Professor,
Ashoka University
-(1)-b06195.png?length=600&name=3912a638-76da-40f1-a77b-a437907d412c-2-11764368speaker_photo-Headshot_Venetis-(1)-(1)-b06195.png)
Konstantinos Venetis
Head of the R&D Team,
IEO Istituto Europeo di Oncologia
Konstanty Korski
Senior MD Pathologist,
Roche
Kristin Hellman
Global Product Manager,
Olink, part of Thermo Fisher Scientific
Krzysztof Kolmus
Principal Scientist,
Ingenix
Lorcan Sherry
Chief Scientific Officer,
OracleBio
Lucas Rifkin
Executive Medical Director, Global Head of Medical & Scientific Affairs,
Labcorp
Maciej Cabanski
Vice President Biomarkers and CDx,
Monte Rosa Therapeutics
Magda Meissner
Consultant Medical Oncologist, Clinical Liquid Biopsy Lead,
Cardiff University
Maham Ansari
Senior Director, IVD Regulatory,
Precision for Medicine
Marco Tecilla
Scientific Area Lead Digital Pathology,
Roche
Marie-Christine Bakker
MD-Researcher in Medical Oncology,
UMC Utrecht
Mario Kreutzfeldt
Deputy Lab Manager, Computational Pathology and Clinical Bioinformatics Laboratory,
Geneva University Hospitals (HUG)
Martí Jimenez Mausbach
Associate Scientific Director,
Novo Nordisk
Megan O’Shaughnessy
Scientific Affairs Specialist,
ICON
Michael Rebhan
Associate Director,
Novartis
Michal Rosen Zvi
Head of AI for Drug Discovery and Translational Medicine,
Merck
Mirella El Khoury
Senior Field Application Scientist,
Quanterix
Miro Venturi
Chief Executive Officer,
DIAMANTE Healthcare Consulting
Nikolas Stathonikos
Principal Investigator AI Development & Implementation,
UMC Utrecht
Nina Linder
Professor,
Uppsala University
Nina Linder
Founder,
Foundation Medicine
Nina Skorytchenko
Chief Executive Officer,
Avenna
Oskar Smrzka
CEO/CSO,
Ablevia biotech GmbH
Özlem Akilli
Director Department of Spatial Biology and Cellular Dynamics,
TRON Translational Oncology Mainz
Paolo Paganetti
Head of Clinical & Laboratory,
Tivenix SA
Patrick Weber
Sales Solution Specialist,
Leica Microsystems, Inc.
Paul Mesange
Senior. Director, Lab Operations - Global Anatomic Pathology,
Labcorp
Paul Workman
Harrap Professor of Pharmacology and Therapeutics,
The Institute of Cancer Research, London
Peter Schüffler
Professor for Computational Pathology,
Technical University of Munich
Petra Kukkaro
Global Biomarker Diagnostic Director,
Novartis
Philip Beer
Chief Scientific Officer,
Step Pharma
Philip Zimmermann
Chief Executive Officer,
Prevision Medicine AG
Pierre Moulin
Chief Scientific Officer,
Deciphex Inc DBA Diagnexia US
Pim French
Professor Molecular Biology of Gliomas,
Erasmus MC
Priyanka Dutta Passecker
Chief Business Officer,
CellPly
Rachel Agoglia
Manager, Global Pharma Applications & Bioinformatics,
Mission Bio
Raif Yuecel
Director, Centre for Life Science Technologies,
University of Exeter
Régis Villet
VP, Commercial Strategy and Medical Innovation,
Synexa Life Sciences
Rene Kubiak
Global Head Early Development & Non-Clinical Biostatistics,
Sanofi
Our Sponsors for Precision Medicine Europe 2027
Network & Programme Sponsors
Sponsors of Biomarkers, CDx & Precision Medicine 2026 included
Almac Group
Silver Sponsor
Almac Diagnostic Services is a precision medicine company specialising in biomarker driven clinical trials. Our global CLIA and CAP accredited laboratories cover UK, Europe, USA and APAC regions.
Our core services include:
• Multi-Omic Services
• Clinical Biomarker & CDx Development
• Clinical Testing
Make the winning move today
www.almacgroup.com/diagnostics
Arcoris Bio
Network & Programme Sponsor
arcoris bio AG is a Swiss life science company advancing biomarker detection with MUSE®, an enzyme-free DNA nanotechnology.
Our immunoMUSE® kits deliver ready-to-use signal amplification for multiplex immunofluorescence workflows, enabling more sensitive protein detection. Alongside these kits, we offer custom solutions for RNA FISH, FACS and other assay formats, supporting scientists and partners in research and diagnostics worldwide.
Our solutions are used by scientists in the fields of cancer, immunology, genetics, neuroscience, developmental biology, translational and pharmaceutical research and others, enabling new insights into biology and diseases.
We envision a future where our technology not only accelerates research but also transforms diagnostics and hence provides better cures.
Ardena
Network & Programme Sponsor
Ardena is a CDMO and bioanalytical CRO specializing in complex drug development, including drug product development, nanomedicine, and bioanalytical services. With facilities across the US and Europe, we combine scientific expertise with responsive support to accelerate innovative therapeutics and make precision medicine more accessible to patients.
Aspect Analytics NV
Network & Programme Sponsor
Aspect Analytics’ Weave platform turns spatial multi-omics data and AI-powered analysis into actionable biological insight. We help research, biopharma, and clinical teams uncover cellular context others miss, move from raw data to decision faster, and make spatial biology accessible to every team member, on enterprise-grade, FAIR-compliant infrastructure.
Barco Healthcare
Network & Programme Sponsor
Barco, a leading global technology company, specializes in developing high-tech visualization,
networking, and collaboration solutions for healthcare, enterprises, and entertainment.
With five distinct business units covering meeting rooms, control rooms, entertainment, cinema,
and healthcare, Barco's tech is seamlessly integrated into various aspects of our daily lives.
From improving teamwork in meeting rooms with ClickShare and enabling quick decisions in
control rooms to providing immersive entertainment with advanced projectors and image
processing to ensuring quality care with top-notch medical solutions, Barco's impact is felt across
diverse industries.
Established in 1934 in Belgium as a TV and radio company, Barco has grown into an international
tech company with strong European roots. Embracing a culture of collaboration that transcends
borders and nationalities, Barco believes in the power of diversity to drive innovation.
Today, headquartered in Kortrijk, Belgium, Barco boasts a global team of over 3,000 ‘visioneers’
and is publicly listed on the Brussels Stock Exchange.
Becton Dickinson
Gold Sponsor
BD is one of the largest global medical technology companies in the world and is advancing
the world of health by improving medical discovery, diagnostics and the delivery of care.
The company develops innovative technology, services and solutions that help advance both
clinical therapy for patients and clinical process for health care providers. BD has more than
70,000 employees and a presence in virtually every country around the world to address
some of the most challenging global health issues. BD helps customers enhance outcomes,
lower costs, increase efficiencies, improve safety and expand access to health care.
bd.com
Bio-Techne Spatial
Silver Sponsor
Bio-Techne Spatial, a leader in applied spatial biology solutions, empowers scientists and clinicians around the world to push the boundaries of science and medicine. Bio-Techne Spatial is built on technological excellence to deliver targeted, scalable spatial biology solutions and accelerate breakthroughs that improve patient lives. Powered by the gold-standard RNAscope™ technology and the end-to-end COMET™ Suite, the comprehensive ecosystem of best-in-class reagents, instruments, and analysis software enables versatile and reliable workflows for RNA, protein, and multiomic detection with unmatched analytical performance.
BioAgilytix
Network & Programme Sponsor
BioAgilytix is a leading global bioanalytical laboratory providing established and innovative bioanalytical services to pharmaceutical and biotechnology companies. With laboratories in North America, Europe, and Australia, BioAgilytix supports programs from discovery through late-stage clinical development with expertise in pharmacokinetics (PK), immunogenicity, biomarkers, GMP testing and Analytical services. For more information, please visit www.bioagilytix.com
-(2).jpg-d7e880.png?length=600&name=062dfa12-6253-4927-aadf-985b6e8216fd-2-5668375logo-Biolizard_black-(1)-(2).jpg-d7e880.png)
BioLizard
Silver Sponsor
BioLizard is a leading multi-national data analytics and data management consulting company supporting digital transformation in the life sciences industry by offering bespoke, tailored solutions. From data analytics and bioinformatics, to software development and AI, we support biopharma and biotech companies in accessing vital, data-driven insights that can be turned into actions and drive your life sciences research forward.
Our team of experienced bioengineers, software engineers and computer science experts combines extensive data science expertise with deep biological knowledge to provide solutions that are tailored to your needs and in line with your unique strategic goals. We have a proven ability to support companies from discovery to pre- & early clinical phases, enabling data-driven R&D.
Our expertise spans drug and biomarker discovery and development, in-silico screening, target identification, development of companion diagnostics, mechanism-of-action studies, process automation, data strategy, and more. No matter where you are, we’re ready to help you leverage data to keep your competitive edge. Reach out to BioLizard today to get the most out of your data.
Carl Zeiss Microscopy
Bronze Sponsor
ZEISS Microscopy empowers Biotech and Pharma industries with innovative imaging and workflow solutions for Tissue Multiplexing, 3D Human Tissue Models, and advanced Regulatory and Compliance workflow integration. Leveraging over 175 years of excellence in the fields of optics and optoelectronics, ZEISS combines cutting-edge microscopy solutions with expert Professional Services to enable accelerated discoveries, reproducible results, and regulatory readiness, helping you advance therapies and improve patient outcomes with confidence.
Cavidi
Network & Programme Sponsor
Cavidi enables ultra-sensitive detection of low-abundance biomarkers with established immunoassays. Its Exazym® reagent-based add-on integrates into existing workflows to offer significant signal amplification, while retaining current antibody pairs and equipment where validated. Exazym® is built on BOLD (Binding Oligo Ladder Detection) technology, which emerged from Cavidi’s COVID-19 diagnostic efforts and has since been applied across infectious-disease, cardiac, neurological, and cytokine research. With more than 40 years of expertise in reverse-transcriptase-based technologies, Cavidi brings a deep technical heritage to the development of advanced biomarker detection solutions.
CellCarta
Bespoke Platinum
CellCarta is a leading global CRO laboratory to the biopharmaceutical and biotechnology industries, partnering with translational medicine, biomarker, and clinical development teams to generate reliable, regulatory-ready data for complex clinical programs. With fully owned and harmonized laboratory operations across North America, Europe, Australia, and China, CellCarta delivers integrated capabilities spanning immunology, histopathology, proteomics, and genomics, supported by comprehensive sample management and logistics solutions. Combining deep scientific expertise with globally consistent execution, CellCarta supports highly customized biomarker strategies and large-scale global studies across the full biomarker continuum — from translational research through clinical development and companion diagnostic (CDx) advancement. For more information, visit cellcarta.com and connect with CellCarta on LinkedIn and X.
Cerba Research
Bronze Sponsor
Cerba Research is a global specialty laboratory and biomarker solutions partner supporting the development of precision medicines from discovery through commercialization. Combining deep scientific expertise across biomarkers, genomics, flow cytometry, histopathology and bioanalysis with integrated central laboratory management, Cerba Research helps biopharma companies generate high-quality, actionable data at scale. Its global laboratory network and centralized operational model provide harmonized testing, sample logistics, project management and scientific oversight across multinational clinical trials. By uniting specialist science with operational excellence, Cerba Research enables sponsors to accelerate biomarker-driven development, improve study efficiency and advance personalized healthcare worldwide
Crown Bioscience Germany
Network & Programme Sponsor
Crown Bioscience Germany GmbH focuses on Biospecimen Services, offering high-quality human biospecimens and integrated biomarker services to support oncology and immuno-oncology research.
Our unique biobank comprises nearly one million clinically annotated patient samples, offering unparalleled quality and depth of associated clinical data. Through our extensive network across the United States, Europe, and Asia we ensure controlled and consistent access to surgical tissue and blood samples.
Beyond high-quality biospecimen supply, the Biospecimen Services business offers integrated capabilities in clinical biomarker and translational research. By combining high-quality samples with advanced technologies such as immunohistochemistry and spatial transcriptomics, we support our client’s biomarker discovery, validation and clinical studies across the drug development pipeline.
With sites in Europe and US, our team of experts is dedicated to advancing precision medicine and accelerating drug development.
-87ce5e.jpg?length=600&name=3f481de8-1f2a-435c-9e7e-2650eb824415-2-5668375logo-Cyentia-logo-RGB_FINAL-(1)-87ce5e.jpg){kind=logo}
Cyentia Biosource
Entry Exhibition
Cyentia Biosource provides researchers with access to high-quality, ethically sourced human biospecimens. Leveraging our extensive clinical network of vetted partners, we offer prospectively collected fresh or preserved samples with detailed clinical annotation, tailored to meet specific client needs. In addition, we provide access to banked human tissues and biofluids from both disease state and control donors. Our mission is to set the industry standard in biospecimen provision through rigorous feasibility assessment, ethical sourcing, and uncompromising quality so researchers can trust every sample and accelerate scientific discovery.
Cytario
Network & Programme Sponsor
cytario® — The Interoperable Open Platform for Computational Pathology & Spatial Biology
cytario® is a cloud-native but on-prem compatible, web-based platform for whole-slide imaging, multiplexed immunofluorescence (mIF), and spatial-omics analysis. Built for modern 16-bit, multi-channel data that breaks most viewers, cytario® renders whole-slide images — and millions of cells from segmentation overlays — directly in the browser.
What makes cytario® different is its open-source architecture: an auditable, self-hostable platform (AGPL-3.0 core with optional commercial plugins) built on established standards and proven components. Alongside the open-source approach, cytario® takes a path of radical interoperability, making sure every single feature is utilizing established standards as much as possible.
From biomarker discovery and translational research to regulated, GxP-aligned workflows, cytario® lets biomarker teams and CROs view, quantify, and share multiplexed spatial data without vendor lock-in — and without spiraling storage costs.
Deciphex
Platinum Sponsor
Advancing precision medicine requires more than digital pathology. It takes the right combination of expert pathology, scalable workflows, AI, and technology built for modern clinical research.
Patholytix support pharmaceutical companies across the full pathology lifecycle, from early translational research through complex clinical trials, providing a combination of:
End-to-end research and clinical trial pathology services
Flexible Image Management System (IMS)
Global network of specialist pathologists
Decision-ready pathology data for faster, more confident development
Whether you're developing a companion diagnostic, validating a digital biomarker, or managing a global clinical trial, Patholytix helps you unlock more value from your tissue data.
ERBC Group
Network & Programme Sponsor
ERBC is a leading preclinical Contract Research Organization (CRO) dedicated to bridging the gap between research and clinical success. We provide innovative and predictive preclinical models, integrated services, and expert consultancy to assess the efficacy and safety of new compounds. Our comprehensive portfolio supports biopharmaceutical, chemical, and agrochemical industries in de-risking innovation and accelerating R&D productivity. Operating from state-of-the-art facilities across Europe, ERBC combines scientific excellence, customer-centric project management, and a strong commitment to ethical research, including the advancement of alternatives to animal testing.
_horizontal-fire.png?length=600&name=45f9b4c7-7256-481e-99be-7800f07088e7-2-5668375logo-FMI(R)_horizontal-fire.png)
Hamamatsu
Network & Programme Sponsor
Hamamatsu Photonics is a global leader in photonics technology, developing products and systems that enable the visualization, measurement, and analysis of light. Since 1953, Hamamatsu has applied its expertise in imaging, sensing, and analytical technologies to support scientific research, healthcare, industrial innovation, and advanced manufacturing.
Hamamatsu delivers integrated imaging solutions across pathology, spatial biology, and translational research. The portfolio combines NanoZoomer® digital pathology scanners for high-resolution whole-slide imaging with MoxiePlex® multispectral imaging for multiplex tissue analysis, enabling researchers and pathologists to connect tissue morphology, biomarker expression, and spatial context within a single workflow. Together, these technologies support the transition toward connected, data-driven, and AI-ready laboratory environments.
Hologic Diagenode SA
Bronze Sponsor
Hologic Diagenode is a leading provider in the field of epigenomics, with over 20 years of expertise. Our services can help you advance biomarker discovery and drug development by combining the strengths of epigenomics and bioinformatics. This new dimension of epigenomics can offer novel insights that extend beyond genomics, aiding in early detection, patient screening, treatment monitoring, minimal residual disease (MRD), drug efficacy and much more. We partner with you to create a customized, end-to-end service utilizing the best available technology to shorten timelines for translational research and biomarker validation before clinical trials.
.jpg?length=600&name=d7563f0d-f009-49cd-8a2d-f682a079a3bb-2-5668375logo-ICON-Positive-logo-JPEG(nostrap).jpg){kind=icon}
ICON Clinical Research Ltd
Network & Programme Sponsor
ICON plc is a world-leading clinical research organisation. Offering deep operational and medical expertise we accelerate innovation, driving emerging therapies forward to improve patient outcomes. From molecule to medicine, we deliver integrated consulting, clinical development, commercialisation and post-marketing solutions to pharmaceutical, biotechnology, medical device, government and public health organisations worldwide. With headquarters in Dublin, Ireland, ICON employed approximately 40,200 employees in 99 locations in 55 countries as at June 30, 2026. For further information about ICON, visit: www.iconplc.com.
Illumina
Platinum Sponsor
At Illumina, our mission is to improve human health by unlocking the power of the genome. Our sequencing by synthesis chemistry is used to generate high-accuracy DNA and RNA sequence data in studies around the globe. The innovative products that we provide are helping drive advancements in a multiomic understanding of cellular functions, combining transcriptomics, epigenetics, and proteomics. Multiomics profiling studies enable a more comprehensive understanding of development, cellular response, and disease, fueling the discovery of novel drug targets and biomarkers. The progress our customers have made and what lies ahead inspire us to push the boundaries of what is possible so we can create the next generation of genomics solutions.
Indica Labs
Bronze Sponsor
Indica Labs, the global leader in AI-powered digital pathology, is redefining medicine with pathology platforms supporting life science discovery, translational research, clinical workflows, and companion diagnostic development. HALO platforms integrate image management and quantitative image analysis to deliver standardized, reproducible tissue-based analysis at every stage of the translational journey.
IQVIA Laboratories (Rules-Based Medicine, an IQVIA business)
Silver Sponsor
IQVIA Laboratories is a global leader in drug discovery and development laboratory services, offering a comprehensive suite of central laboratory and specialty biomarker services.
In a complex environment, we work closely with customers to understand their unique needs and provide the right mix of in-depth scientific and operational expertise, specialty lab services and next-generation lab technologies to achieve their goals with efficiency. At each stage of drug discovery and development, the IQVIA Laboratories team is ready to deliver timely and reliable outcomes, turning innovative ideas into groundbreaking milestones for patients in need.
Labcorp
Diamond Sponsor
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests for patients around the world. Learn more at www.labcorp.com.
Leica Microsystems
Bronze Sponsor
Leica Microsystems, a Danaher company, provides integrated imaging and analysis solutions that enable the generation of insight from complex imaging to support faster, informed decisions across life science, medical, and industrial applications. Guided by our purpose to reveal what is invisible, we partner with customers to turn this insight into impact, contributing to a better and healthier world.
Our portfolio spans workflows from sample preparation to AI-enabled analysis, built on more than 175 years of microscopy experience and a culture of continuous improvement, customer focus, and innovation.
Headquartered in Wetzlar, Germany, we operate globally with manufacturing and development sites and serve customers in more than 100 countries.
Logical Biological
Network & Programme Sponsor
Logical Biological deliver a sustainable supply of human biological materials to a global customer base, including biospecimens, bulk disease state plasma, tissues and cells. Through our deep understanding of science and customer needs, we bridge gaps in material provision and deliver exceptional service and attention to detail, supporting diagnostics and therapeutic research, development, and IVD control manufacture.
We understand the challenges our customers face including gaps in material availability, inconsistent service, and the need for precise, data rich, high-quality materials delivered reliably. Our approach combines a comprehensive offering of disease state biofluids, tissues and cells, rigorous attention to quality and documentation, and responsive customer support to help you move forward faster.
Luminex Corporation
Silver Sponsor
Luminex leads innovation and pioneers scientific breakthroughs using xMAP® Technology: a platform that has spearheaded advancement in both applied and fundamental research since 1999. Our mission to empower labs to obtain reliable, timely, and actionable answers is made possible through trusted testing solutions and proven, reliable custom assay development services that provide scientists with dependable answers to intricate scientific challenges. Our impact extends globally, shaping healthcare practices and improving bioscientific research worldwide. With an unwavering commitment to innovation and excellence, Luminex continues to lead the charge in advancing applied and fundamental research.
Merck & Cie KmG
Network & Programme Sponsor
We are Merck , researchers around the world rely on our tools, services and expertise to do their best science — from familiar experiments to novel approaches. Our presence extends well beyond the labs as our innovations touch individuals around the world. Together, we impact life and health with science.
Meso Scale
Network & Programme Sponsor
Meso Scale Discovery (MSD) biomarker assays provide a rapid and convenient method for measuring the levels of targets within a single, small-volume sample. The MSD product line offers a diverse menu of assay kits for profiling biomarkers, cell signaling pathways, and other applications. ProteinXI, a division of Meso Scale Diagnostics, LLC., is a discovery proteomics platform that enables absolute quantitation and has a built-in translational route to MSD.
Metabolon, Inc.
Network & Programme Sponsor
Every biological process leaves a biochemical signature. Genetics, disease, the microbiome, diet, lifestyle and environmental exposures all influence the biochemicals circulating through cells, tissues and biofluids. By measuring these small molecules at scale, metabolomics provides one of the closest views of biological function available.
Metabolon is the global leader in metabolomics, delivering high-quality, large-scale biochemical profiling that helps researchers gain deeper insight into biology. From a single biological sample, our technology measures thousands of metabolites, providing a comprehensive snapshot of physiological state and revealing biological changes associated with disease, therapeutic intervention, nutrition and environmental factors. These insights help advance biomarker discovery, drug development, precision medicine and population health.
Our scientific leadership is built on the world's largest metabolomics reference library, containing more than 5,400 known compounds, together with industry-leading analytical platforms and 26+ years of metabolomics expertise. This unique combination enables researchers to identify novel biology with confidence and generate reproducible, actionable data.
Since our founding in 2000, Metabolon has supported more than 15,000 independent and collaborative studies, contributing to over 4,000 peer-reviewed publications. Headquartered in Research Triangle Park, North Carolina, we partner with pharmaceutical, biotechnology, academic, healthcare and nutrition organizations worldwide to accelerate scientific discovery and improve human health.
Meteor Biotech
Bronze Sponsor
Meteor Biotech, headquartered in Seoul, South Korea, is at the forefront of innovation in the realm of spatial omics, specializing in advanced technologies that revolutionize the study of complex biological systems. As a trailblazer in the field, our flagship product, the CosmoSort device, leverages our proprietary Spatially-resolved Laser Activated Cell Sorting (SLACS) technology. This cutting-edge tool provides unparalleled precision in cell isolation, enabling detailed genomic, transcriptomic, and proteomic analyses with spatial context. Founded and led by a team of engineers and scientists, Meteor Biotech combines rigorous scientific expertise with a commitment to advancing biomedical research. Our multidisciplinary team comprises renowned experts dedicated to developing solutions that address the critical challenges in translational medicine, cancer research, neurodevelopmental studies, and beyond. At Meteor Biotech, we are not just creating tools;we are empowering scientists and researchers around the globe with the ability to unlock the mysteries of cellular heterogeneity and molecular interactions. Our presence at the Biomarkers & Precision Medicine conference is an opportunity to connect with the scientific community, share insights, and foster collaborations that will shape the future of spatial omics research.
Methylomics
Bronze Sponsor
Methylomics is an emerging company from The Netherlands, focused on methylation-based cancer diagnostics. The founders of Methylomics have developed MeD-seq, a scalable, genome-wide methylation analysis tool. MeD-seq analyzes methylation at 16.5M CpG sites at a fraction of sequencing depth needed for conventional methods, with an robust and scalable workflow. It is compatible with low input or degraded samples such as cfDNA (liquid biopsies) and FFPE samples and has potential for multi-omic data extraction. MeD-seq can be used as 1) a biomarker discovery tool for any oncology or non-oncology application, and 2) directly as a clinical diagnostic tool for cancer diagnosis, classification and monitoring. Currently we are offering MeD-seq as a service in research projects and actively looking for partnerships.
Our internal development programs are currently focused on gynaecological and lung cancers.
In addition, we have used MeD-seq as a biomarker discovery engine in the gynaecological cancer space and are currently developing MeD-scan, a highly sensitive and specific qMSP test with two patented markers for cervical and endometrial cancer detection.
Together with our partners and customers, we are progressing MeD-seq in various biomarker discovery and clinical projects.
Miltenyi Biotec B.V. & Co. KG
Network & Programme Sponsor
Miltenyi Biotec is a global leader in innovating technologies and services for patient-specific cell and gene therapies, transforming scientific discoveries into practical treatments for personalized medicine. With over 35 years of expertise, it supports biomedical discoveries and translates them into clinical applications, enhancing patient access to new therapies. Miltenyi Biotec focuses on offering integrated solutions for complex challenges in treating cancers, autoimmune diseases, and inherited disorders. Its Miltenyi Bioindustry division provides expert guidance to therapy developers efficiently from process development to commercialization. Headquartered in Bergisch Gladbach, it employs over 5,000 people across 27 countries.
Mission Bio
Bronze Sponsor
Mission Bio is the single-cell multi-omics leader. The company’s Tapestri Platform is unique in its capabilities, offering an unparalleled level of granularity and precision that is critical for complex research areas such as cancer studies, pharmaceutical development, and advanced cell and gene therapies. Unlike traditional standard-of-care methods, Tapestri provides a level of precision that opens the door for more tailored and effective treatment strategies, notably by advancing the clinical utility of measurable residual disease (MRD) monitoring in diseases like acute myeloid leukemia (AML). Researchers globally depend on Tapestri to identify rare cell populations, understand mechanisms of therapeutic resistance and response, and establish key quality metrics for next-generation medical treatments. With the Tapestri Platform, Mission Bio continued to set the standard in the field, contributing significantly to the progress of personalized medicine and targeted therapies. To learn more about Mission Bio and the Tapestri Platform, please visit missionbio.com.
OHMX.bio
Network & Programme Sponsor
OHMX.bio helps pharma and biotech teams turn multi-omic, genomic and immuno-biomarker questions into actionable data. We work across the journey from biomarker discovery and translational research to the development and implementation of clinical assays.
Contact our team members for a free consultation on your biomarker strategy, and let's discuss our array of available technologies, expertise and end-to-end solutions. OHMX.bio relies on 25+ years of experience and is well equipped to deliver high quality (GCLP) solutions, flexible setups and fast turn-around-times. Take advantage of our varied expertise to come up with custom (multi)omic biomarker tailored to your needs.
Originally established as a genomics and bioinformatics spin-off from Ghent University, OHMX.bio became part of the Anacura Group in 2024. Today, we have a presence in Belgium and Switzerland, supporting pharmaceutical companies, biotech teams and translational research groups across Europe.
For partners working on targeted therapies, patient stratification or biomarker-driven clinical development, we provide a practical bridge between biological insight, robust analytical workflows and assays that can ultimately be used in the clinic.
Olink Proteomics, part of Thermo Fisher Scientific
Bespoke Gold
Olink, part of Thermo Fisher Scientific, offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways. Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base.
.png?length=600&name=9214d899-bb36-424c-bc38-71826b37f343-2-5668375logo-OracleBio-Icon-Text-Logo-Black-Large-(Transparent-Background).png){kind=spacer}
-f5cf34.png?length=600&name=bc795188-53d2-4e05-bf81-b93534ad91dc-2-5668375logo-pathcore_logo_color_675_200-(4)-f5cf34.png){kind=logo}
Pathcore
Network & Programme Sponsor
Pathcore® provides flexible, reliable digital pathology image management systems built for the demands of preclinical research, including toxicologic pathology and spatial biology. Our secure and GLP-compliant enterprise platform, PathcoreFlow, integrates with your existing systems, supports all major WSI formats and DICOM, and scales to fit AI and storage needs, without the cost or complexity of bloated alternatives. Reduce download time, delays and travel. Stop by our booth to see Pathcore for yourself.
-44cf36.png?length=600&name=c2daabdc-5f3e-457a-a15e-dba957a74d21-2-5668375logo-PFM_RGB-(R)-44cf36.png)
Precision For Medicine
Silver Sponsor
Precision for Medicine is the first biomarker-driven clinical research and development services organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively. Precision applies a transformational approach to clinical research that integrates clinical trial design and execution with deep scientific knowledge, laboratory expertise and advanced data intelligence. For more information, visit PrecisionForMedicine.com.
Precursion
Network & Programme Sponsor
Precursion is a CRO specializing in biomarker discovery, translational research, and precision medicine, offering tailored multi-omics services.
Working with biotechnology and pharmaceutical companies, academic institutions, and research organizations, Precursion brings together expertise in biobanking, genomics, proteomics, and bioinformatics. Its technology portfolio includes ctDNA analysis, long-read sequencing with PacBio Revio, high-throughput proteomics with Olink, transcriptomics, single-cell analysis, and other multi-omics approaches.
With facilities in France and the United States, Precursion combines advanced multi-omics technologies with a strong CAP/GCLP and ISO quality environment to generate high-quality data.
Customized scientific support is embedded in Precursion's DNA. From study design and sample management to data analysis and biological interpretation, Precursion supports its clients throughout the entire research process. By providing expert guidance and solutions tailored to each project's specific needs, Precursion maintains the highest standards of quality, reliability, and reproducibility.
.png?length=600&name=f90ba4ee-dc07-414e-8829-9ceb80d149e6-2-5668375logo-Proscia-(14).png)
Proteome Sciences plc
Network & Programme Sponsor
Proteome Sciences is a CRO specialising in the analysis of proteins detected by Mass Spectrometry. We offer various Discovery and Targeted Services to characterise proteins and their associated post translational modifications. By using LC-MS2, SysQuant® and TMTcalibratorTM methodologies we can detect up to 8,000 of proteins/sample. With our proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment.
These key protein biomarkers can then be measured in a GCLP accredited Targeted Assay in a clinical trial, via a multiplexed assay of up to 100 proteins/sample.
New! We now offer Solvent Shift chemoproteomic analysis.
New! We have just opened a full service lab in San Diego!
New! New services based on TMT-32 plex available now!
Quanterix
Silver Sponsor
Quanterix is a global leader in precision biomarker science, making biology measurable to deliver earlier insights and support breakthroughs in disease research, diagnostics, and drug development. Its Simoa® technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. Through the acquisition of Akoya Biosciences, Quanterix Spatial solutions deliver high-plex, quantitative protein analysis in tissue at single-cell resolution. Combined with Accelerator Laboratory services, Quanterix gives researchers the tools and expertise to translate discovery into precision diagnostics. Learn more at www.quanterix.com.
Randox Biosciences
Network & Programme Sponsor
Randox Precision Medicine Centre partners with pharmaceutical and biotechnology companies to transform biomarkers into clinically actionable insights that accelerate drug development and improve patient outcomes. Specialising in clinical trial-driven patient stratification, we support the identification, validation, and deployment of biomarkers that enable the selection of the right patients for the right therapies, increasing trial efficiency and advancing precision medicine strategies from early discovery through to commercialization. Through our ISO 15189 and CLIA-accredited laboratories, we provide end-to-end capabilities including biomarker discovery and validation, companion diagnostic development, multi-omics research, genomics and NGS, clinical sample testing, and real-world evidence generation. At the core of our offering is RANCHIP® (Randox Biochip Array Technology), a proprietary multiplex platform that delivers comprehensive biomarker profiling from a single sample, generating deeper biological insights while conserving valuable clinical specimens. By combining scientific expertise, advanced laboratory infrastructure, and scalable testing capabilities, Randox enables sponsors to de-risk development programs, enhance patient stratification, demonstrate therapeutic value, and generate the clinical evidence required to bring innovative precision medicines to market faster and more effectively.
.png?length=600&name=3ebab810-7368-4d37-bc16-77d994699581-2-5668375logo-RareCyte_Logo_PMS7585-CoolGray11-(R).png){kind=logo}
RareCyte
Bronze Sponsor
RareCyte enables high-confidence precision biology through advanced spatial biology and liquid biopsy technologies. Our solutions provide quantitative, high-quality data to help researchers characterize complex disease biology, understand the tumor microenvironment, develop biomarkers, and advance therapeutic development. RareCyte’s Orion™ spatial proteomics platform enables high-plex quantitative analysis of tissue, while our CyteFinder® liquid biopsy technologies enable highly sensitive detection and characterization of rare cells. Together, these complementary technologies provide powerful approaches for advancing biomarker-driven precision medicine.
Real Chemistry
Bespoke Sponsorship
About Real Chemistry: 25 Years of Future-Focused Healthcare.
Celebrating its 25th anniversary this year, Real Chemistry is a tier-one commercialization partner to the world’s most innovative life sciences and healthcare companies. As a leading provider of AI-powered audience analytics and insights, Real Chemistry helps the healthcare industry better understand, reach and engage critical audiences to improve the healthcare experience for all. Anchored by a culture of innovation and creativity, Real Chemistry’s 2,400+ global experts across life sciences, marketing communications and technology are singularly focused on navigating the complexities of bringing scientific advances to market — and to the people who need them most. Real Chemistry’s brand portfolio includes 21GRAMS, a highly awarded creative agency, and starpower, a celebrity and influencer practice.
Today, Real Chemistry operates through offices across North America, Europe, the Middle East and Asia Pacific, complemented by a strategic partner network in Latin America and Africa — enabling the company to support clients wherever they operate.
Revolune
Bronze Sponsor
Revolune is a life science company dedicated to making multiplex immunofluorescence as accessible and practical as routine tissue analysis. Its reagent technologies are designed to help laboratories move rapidly from their existing primary antibodies to ready-to-use multiplex kits, simplifying spatial biology workflows, reducing operational complexity, and enabling researchers to focus on biological questions rather than assay management. Revolune supports researchers across oncology, translational medicine, and biopharmaceutical development with scalable multiplex solutions built for real-world laboratory environments.
Seer
Gold Sponsor
Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics—delivering insights with scale, speed, precision, and reproducibility previously unattainable by other proteomic methods. Seer’s Proteograph Product Suite uniquely integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables, and advanced analytical software to solve challenges conventional methods have failed to overcome. Traditional proteomic technologies have struggled with inconsistent data, limited throughput, and prohibitive complexity, but Seer’s robust and scalable workflow consistently reveals biological insights that others do not. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information about Seer’s differentiated approach and ongoing leadership in proteomics, visit www.seer.bio.
Singular Genomics
Silver Sponsor
Biomarker programs stall where the tissue runs out. Singular Genomics is a spatial multiomics services lab in San Diego built for the stage after discovery: targeted, validated assays at cohort scale, not a handful of blocks. Send an FFPE section, get a co-registered single-cell map in about five days, no instrument to install or validate. One run on the G4X platform reads 500-plex RNA alongside 18-plex protein and fluorescent H&E from the same section at subcellular resolution, 6.2 million cells to a flow cell, so a marker is measured in the same coordinates as the morphology a pathologist reads, on the same cells. For companion diagnostics the question is rarely whether a target is present and almost always where it sits, in which cells, and how it varies across a cohort. One run images 40 square centimeters across 16 lanes and takes up to 128 samples, so a cohort is a run, not a program. Curated panels cover six cancer types and customize to the full 500 genes, across 41 indication-specific designs. The same assay reads human and mouse FFPE, so preclinical and clinical cohorts measure the same way. Every run carries QC floors: transcripts per cell, segmentation success, negative control probe rate, fraction of region imaged. What comes back is a cell-by-gene matrix with spatial coordinates, cell type calls, segmentation masks and a written assessment. All services are for research use only, not for use in diagnostic procedures. Find the Singular team in Switzerland, or write to services@singulargenomics.com.
Synexa Life Sciences Ltd.
Silver Sponsor
Synexa Life Sciences is a specialist biomarker CRO dedicated to advancing precision medicine through innovative biomarker solutions for clinical development and translational research. With more than 200 scientific experts across laboratories in Manchester (UK), Turku (Finland) and Cape Town (South Africa), Synexa partners with pharmaceutical and biotechnology companies to identify, develop, validate and analyse biomarkers that accelerate drug development and support critical clinical decision-making.
Our expertise spans the full biomarker lifecycle, from biomarker strategy and assay development to validation and global clinical trial sample analysis. We support a broad range of biomarker programmes across immunology, oncology, infectious diseases, rare diseases and other therapeutic areas, delivering actionable insights that help sponsors understand drug activity, patient response, mechanism of action and treatment outcomes.
Synexa offers industry-leading capabilities in soluble biomarker analysis, immunoassays, flow cytometry, ELISpot, Fluorospot and genomic services, enabling the generation of high-quality biomarker data to support translational and clinical research objectives. Our scientific teams are known for solving complex biomarker challenges, transforming innovative ideas into robust, reliable assays that drive successful clinical development programmes.
Visit www.synexagroup.com to learn more.
The Institute of Cancer Research
Bespoke Sponsorship
An independent academic research institute based in London, UK, the ICR collaborates extensively with industry across its full portfolio including with biotech, pharma, MedTech and AI companies, driving scientific innovation into patient benefit. The ICR's Business Development team is attending the Biomarkers, CDx and Precision Medicine conference to discuss a range of possible collaboration and partnership opportunities arising from its portfolio of research in these areas.
Vizgen
Bronze Sponsor
Vizgen is at the forefront of spatial biology and multiomics innovation. Co-founded by leaders in single-cell and spatial genomics, including Xiaowei Zhuang, PhD, David Walt, PhD, and Jeffrey Moffitt, PhD, Vizgen builds technologies that equip researchers for discovery in foundational biology and human disease. These include its pioneering MERFISH 2.0™ chemistry and MERSCOPE Ultra™ Platform for in situ single-cell spatial genomics. MERFISH is for research use only. Vizgen is headquartered in Waltham, Massachusetts, with R&D and lab services operations in nearby Cambridge. For more information, visit www.vizgen.com or connect on social media X, LinkedIn and Facebook.
Dr. Elaine Joseph
Director, Precision Medicine,
AstraZeneca
Enrico Mossotto
Senior Director,
MeiraGTx
Giorgio Gaglia
Senior Principal Scientist,
Sanofi
Jing He
Associate Director,
Novo Nordisk
Zora Modrusan
Senior Director of Genomics,
Genentech
Aarno Palotie
Research Director of the Human Genomics Program,
The University of Helsinki, Institute for Molecular Medicine Finland FIMM
Aaron Berlin
Chief Technology Officer,
Singular Genomics
Abeer Obaid
Senior Scientist,
Abbvie
Aditi Singh
Director of Bioinformatics,
Wayne State University
Ahmet Coskun
Professor of Biomedical Engineering,
Georgia Institute of Technology
Alex Tamburino
Director, Spatial & Single Cell Multiomics,
Merck & Co
Ali Ebrahimi
Associate Director,
Takeda
Alina Ainbinder
Principal Scientist,
Takeda
Amanda Dy
Reseacher,
Toronto Metropolitan University
Amit Mitra
Associate Professor,
Auburn University
Andrew Owens
Application Scientist,
Mission Bio
Anita Bansal
Associate Director, Lead Translational Bioinformatics,
UCB Pharma
Arutha Kulasinghe
Associate Professor,
The University of Queensland
Ashot Harutyunyan
Academic Associate,
McGill University
Aziz Al'Khafaji
Director, Molecular R&D - Genomics Platform,
Broad Institute of MIT and Harvard
Banishree Saha
Associate Director, Global Biomarker and Assay Analytical Lead,
Takeda Pharmaceuticals
Bharat Thyagarajan
Associate Professor,
University of Minnesota
Carina Emery
Lead Product Manager,
Miltenyi Biotec
Carol Hu
Senior Scientist,
Merck Research Laboratories
Chandra Saravanan
Pathologist,
Novartis Pharma
Chanyoung Park
Research Scientist,
Stellaromics
Colles Price
Co-Founder & Chief Executive Officer,
TALOX
Daniel Carney
Sales Director,
Fovus
Daniel Jones
Staff Scientist,
Fred Hutchinson Cancer Research Center
David Gallegos
Senior Scientist,
Takeda
Di He
Senior Scientist,
Merck
Dr. Deepak Veeregowda
Chief Executive Officer,
QT Sense
Dulguun Amgalan
Staff Scientist,
Illumina AI Lab
Emre Arslan
Associate Director,
Takeda
Eugenia Lyashenko
Senior Principal Scientist, Lab Head,
Sanofi
Fei Chen
Principal Investigator & Assistant Professor,
Broad Institute
Fei Zou
Professor,
University of North Carolina
Fengbo Ren
Founder and CEO,
Fovus
Gabor Balazsi
Henry Laufer Professor,
Stony Brook University
Gervaise Henry
Vice President, Solutions Engineering,
Manifold AI
Gloria Pryhuber
Professor, Department of Pediatrics, Neonatology (SMD),
URMC
Greg Warner
Senior Field Applications Scientist,
Cell Signaling Technology
Gregory Mendez
Principal Scientist,
Sanofi
Gulpreet Kaur
Chief Businesss Officer,
Elucidate Bio
Hagai Marmor-Kollet
Investment Associate,
aMoon Fund
Hansueli Meyer
Senior Director, Site Leader and Head of Systems Integration Spatial Technologies,
Miltenyi Biotec
Heather Knight
Senior Scientist I,
Abbvie
Hua Li
Director of Computational Biology,
Stowers Institute for Medical Research
Ioannis Ragoussis
Professor,
McGill University
Irene Ghobrial
Professor of Medicine, Senior Vice President of Experimental Therapy, Lavine Family Chair for Preventative Cancer Therapy,
Dana-Farber Cancer Institute
Isabella Polic
Graduate Student,
The University of Texas MD Anderson Cancer Center
Iulian Pruteanu-Malinici
Senior Director Bioinformatics,
Flagship Pioneering/Pioneering Medicines
Ivan Lebedev
President,
Verdant Center for Spatial Biology
Jackson Brougher
Assistant Professor & Space Health Research Scientist,
Translational Research Institute For Space Health
Jan Schejbal
Senior Scientist II,
AbbVie
Jeff Byland
Senior Science & Technology Advisor,
10x Genomics
Jeff June
Chief Executive Officer,
Ischemia Care
Jennifer Frahm
Director, Field Application Scientist,
Standard BioTools Inc.
Jia-Ren Lin
Technical Director of Tissue Imaging,
Harvard Medical School
Jiang He
Vice President, R&D, Reagents,
Vizgen
Jiwoon Park
Founder of the Spatial Atlas of Human Anatomy,
Weill Cornell Medicine
Joann Arce
Assistant Professor,
Boston Children's Hospital, Harvard Medical School
Jochen Lennerz
Chair,
EFLM Task Group on Integrated Diagnostics
Joseph Beechem
CSO & Sr. VP of Research & Development,
Bruker Spatial Biology
Kisha Sivanathan
Senior Scientist,
AstraZeneca
Leonard Lipovich
adjunct professor,
Kean University
Madhumala Sadanandappa
Scientist,
Dartmouth Health
Mahmud Hossain
Senior Scientist II,
Sanofi
Manisha Brahmachary
Associate Director,
Sanofi USA
Manoj Kandpal
Director of Research Bioinformatics,
Rockefeller University
Maria Forero
Senior Advisor,
Accelmed
Nicolas Fernandez
Senior Computational Scientist,
Broad Institute of MIT and Harvard
Nir Ben Chetrit
Assistant Professor,
Weill Cornell Medicine
Pei Chen
Principal Scientist,
BMS
Qingqing Wang
Associate Director,
Regeneron
Rea Dabelic
Sr Staff Product Manager,
Illumina
Sahil Seth
Principal Scientist,
Bristol Myers Squibb
Samouil Farhi
Director, Spatial Technology Platform,
Broad Institute
Samuel Harrison
Technology and Application Science,
Miltenyi Biotec
Sara Hamon
Executive Director, Precision Medicine,
Regeneron Pharmaceuticals
Saum Ghodoussipour
Associate Professor,
Rutgers University
Shanye Yin
Assistant Professor,
Albert Einstein College of Medicine
Sharvari Gujja
Data Scientist, Abbvie,
Abbvie Inc.
Shoh Asano
Senior Principal Scientist,
Pfizer
Silvia Siso
Pathologist,
Abbvie
Simona Cristea
Head of Genomics and AI,
Dana-Farber Cancer Institute
Sindi Nexhipi
PostDoc,
DKFZ
Sophia George
Professor,
University of Miami
Soumya Negi
Senior Advisor,
Eli Lilly
Sourav Choudhury
Group Head, Distinguished Scientist,
Sanofi
Stephen Baylin
Head of the Cancer Genetics and Epigenetics Program,
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Steven Barthel
Assistant Professor of Dermatology,
Harvard Medical Scool, Mass General Brigham
Suhas Vasaikar
Associate Director,
Pfizer Ltd
Sunhwa Kim
Associate Scientific Director,
AbbVie
Terry Melim
Sr Research Analyst,
Abbvie
Tes Mersha
Professor,
Indiana University School of Medicine
Tad Geroge
Sr VP Biology R&D,
RareCyte Inc
Tibby Duan
Senior STOmics Product Manager,
Complete Genomics
Tim Harris
Venture Partner,
SV Health Investors
Unsubscribe me
Chief Executive Officer,
AmberGen
Uttiya Basu
Professor,
Columbia University
Vinay Mohta
Chief Executive Officer & Co-Founder,
Manifold AI
Virginia Savova
Board director,
Scailyte
Vitalay Fomin
CEO,
Numenos
William Henley
Co-Founder and VP of Research & Innovation,
Codetta Bio
%20Gao.jpg?length=600&name=Shou-Jiang%20(SJ)%20Gao.jpg)
Xian Wang
Research Project Manager,
University of Pittsburgh
Xuyu Qian
Assistant Professor, Department of Pediatrics, Division of Neurology,
Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania
Yea Jin Kaeser-Woo
Senior Director,
Eli Lilly and Company
Yufei Huang
Professor,
University of Pittsburgh
Zongmei Gao
senior scientist ii,
abbvie
Our Esteemed Sponsors for NextGen Omics & Spatial Biology US 2025
Platinum Sponsors
10x Genomics
Platinum Sponsor
10x Genomics was founded on the vision that this century will bring advances in biomedicine and transform the way we understand and treat disease. We deliver powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Our end-to-end single cell and spatial solutions include instruments, consumables, and intuitive software, letting you unravel highly intricate biological systems, while bringing into focus the details that matter most.
Bruker Spatial Biology
Platinum Sponsor
Bruker Spatial Biology, a division of Bruker Corporation, provides advanced spatial molecular biology solutions, including instruments, assays, software, and services to support life sciences research. By integrating technologies from NanoString and Canopy Biosciences, Bruker offers an extensive portfolio designed to meet the diverse needs of global researchers exploring spatial biology.
The CosMx® Spatial Molecular Imager (SMI) enables high-plex detection and analysis of over 6,000 RNAs with single-cell resolution and precise cell segmentation, supported by the cloud-based AtoMx™ Spatial Informatics Platform. The GeoMx® Digital Spatial Profiler is a leading platform for whole-tissue exploration, providing whole transcriptomics and high-plex proteomic readouts. The CellScape™ Precise Spatial Proteomics platform allows for high-plex protein expression analysis at single-cell resolution, using versatile, open-sourced reagents. The nCounter® Analysis System enables rapid quantification of profiling of gene and miRNA expression with high sensitivity.
Together, Bruker Spatial Biology’s solutions are supported by a strong team of scientists, sales, and service associates, along with Canopy Multiomic Services for biopharmaceutical research, assay development, and clinical sample testing.
For more information, visit www.BrukerSpatialBiology.com.
Gold Sponsors
ariadne.ai
Gold Sponsor
ariadne.ai ag is your partner for biomedical image analysis. Our cloud-based, worry-free SPATIAL platform enables the analysis of multiplexed spatial proteomics, transcriptomics and multi-omics data, including precise stitching, registration, segmentation and statistical analyses of cellular neighborhoods. SPATIAL works with any data type, whether you have fluorescence or histopathological staining, 2d or 3d data, or complex cell types such as neurons. Our experienced team of annotators and software engineers will design and implement custom solutions to any image analysis challenge, no matter the tissue, device or assay.
Cell Signaling Technology
Gold Sponsor
CST® is a privately-owned, global company headquartered in Danvers, Mass., USA. Founded in 1999 and still led by research scientists. We are actively engaged in the development of products and technologies that facilitate signaling analysis and mechanistic cell biology and cancer research.
Miltenyi Biotec, Ltd.
Gold Sponsor
For over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell analysis needs. Our solutions are designed to support everything from basic research to translational research and clinical application for immunology, stem cell biology, neuroscience, and cancer.
Quantum-Si
Gold Sponsor
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® Pro benchtop instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Detecting single amino acids through binding kinetics, the innovative Platinum® Pro benchtop sequencer is highly sensitive to protein variants, enabling deep interrogation of proteins to deliver breakthrough insights.
Singular Genomics
Gold Sponsor
Our recently launched G4X Spatial Sequencer, which is an upgrade to the G4 Sequencing Platform, is designed to offer high throughput in situ direct sequencing of RNA (Direct-Seq™), targeted transcriptomics, and proteomics profiling from formalin-fixed, paraffin-embedded (FFPE) tissues
Vizgen
Gold Sponsor
Vizgen is at the forefront of spatial biology and multi-omics innovation. Through its pioneering MERFISH technology and MERSCOPE® Platform for in situ single-cell spatial genomics and its high-fidelity InSituPlex® protein assays and AI-driven STARVUE™ spatial image analysis technology, Vizgen delivers unmatched tools that enable researchers to uncover deep insights into human biology and achieve breakthroughs in understanding mechanisms of complex diseases. Vizgen’s technology delivers high-confidence, quantitative data with exceptional accuracy, robustness, sensitivity and deep insights that power foundational and clinical research. Vizgen is headquartered in Cambridge, Massachusetts, and can be found online at www.vizgen.com and www.ultivue.com. Connect on social media Twitter, LinkedIn and Facebook.
Silver Sponsors
ACD, Bio-Techne
Silver Sponsor
ACD - a Bio-Techne brand, is a pioneer and leader in the advancement of spatial genomics and clinical applications by unlocking the power of RNA and developing cell- and tissue-based research and diagnostic tests for personalized medicine.
Based in Silicon Valley, ACD’s proprietary RNAscope™ technology, the first multiplex fluorescent and chromogenic in situ hybridization platform, enables detection and quantification of single RNA molecules in situ. Our portfolio includes, RNAscope, BaseScope™, miRNAscope™ and HiPlex™ v2. With over 50,000 probes and our Professional Assay Services, we enable rapid assessment of unique targets. Since launch in 2011, the technology boasts 10,000+ citations, with new peer reviewed publications daily.
Based on proprietary technology, ACD’s RNAscope Technology, the first multiplex fluorescent and chromogenic in situ hybridization platform enables detection and quantification of RNA in situ at single molecule sensitivity.
Ardigen S.A.
Silver Sponsor
Ardigen is a leading AI Contract Research Organisation (CRO) dedicated to increasing the success rate of drug discovery. Recognized among the top 5% of AI in drug discovery companies worldwide, Ardigen integrates expertise in biology, bioinformatics, machine learning, and software engineering to deliver advanced computational solutions exclusively tailored for the biotechnology and pharmaceutical sectors. Over the past 10 years, we have earned the trust of over 120 clients, including 15 major pharmaceutical companies, by providing exceptional in silico research and data engineering services.
Complete Genomics
Silver Sponsor
Complete Genomics is a pioneering life sciences company offering innovative, comprehensive sequencing solutions, including sample/library preparation, lab automation, sequencing, and data analysis. Our sequencing portfolio features a full range of sequencers designed to meet low, medium, and high throughput needs, all powered by our proprietary DNBSEQ technology. To date, over 9,700 publications have utilized DNBSEQ technology across a broad spectrum of applications.
As the exclusive distributor of STOmics products in North America, Complete Genomics provides access to Stereo-seq technology—the only spatial transcriptomics solution worldwide capable of exploring the entire transcriptome at true single-cell resolution.
To learn more, visit https://www.completegenomics.com
GENEWIZ from Azenta Life Sciences
Silver Sponsor
As a global leader in R&D genomics services, GENEWIZ from Azenta Life Sciences, leads the way in providing superior data quality with unparalleled technical support to enable researchers around the world to advance their scientific discoveries faster than ever before.
Our customers at top-tier pharmaceutical, biotechnology, and academic institutions, as well as cutting-edge start-ups, rely on our proprietary technologies for consistent, reliable, high-quality data, even on the most difficult projects. A full-service provider, we provides Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next generation sequencing, bioinformatics, and GLP regulatory services.
Hamilton
Silver Sponsor
Hamilton Company specializes in the development, manufacturing and customization of precision measurement devices, automated liquid handling workstations, and sample management systems. Hamilton's processes are optimized for quality and flexibility. Whether it's a custom needle with a quick delivery time frame, a special length pH sensor, or a comprehensive solution to fully automate your assay workflow, trust that Hamilton products will always meet your needs.
Hamilton Company has been a leading global manufacturer for more than 60 years, with headquarters in Reno, Nevada;Franklin, Massachusetts;Timișoara, Romania;Bonaduz, Switzerland;and subsidiary offices throughout the world.
Lunaphore Technologies SA, a Bio-Techne company
Silver Sponsor
Lunaphore Technologies S.A. – a Bio-Techne brand, is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore provides solutions based on a game-changing chip technology that can extract spatial proteomic and transcriptomic data from tumors and other tissues, transforming any assay into multiplex spatial biology through a streamlined and easily integrated process. Lunaphore empowers researchers in immunology, immuno-oncology, and neuroscience to push the boundaries of scientific discovery and drug development. Lunaphore’s technology enables the identification of biomarker “signatures” with clinical relevance to support the development of diagnostic tools and streamline clinical trials, to ultimately improve patient outcomes. For further information on Lunaphore and its products, please visit https://lunaphore.com.
Navinci
Silver Sponsor
Navinci is a Swedish biotech company specializing in developing innovative solutions for studying protein interactions. With a focus and a strong legacy in developing in situ proximity ligation assay technology, Navinci has established itself as a center of excellence in the field and has a broad portfolio of products that help researchers study protein interactions in depth.
NeoGenomics Laboratories
Silver Sponsor
NeoGenomics is a premier cancer diagnostics company, specializing in cancer genetics testing and information services. We offer one of the most comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing to help them diagnose and treat cancer. We partner with pharmaceutical clients from discovery to commercialization with broad oncology testing capabilities powered by in-house scientific expertise and dedicated project support teams. Our clients benefit from our state-of-the-art molecular technology, from whole exome sequencing, whole transcriptome sequencing, HLA typing, and the proprietary MultiOmyx™ high-order multiplexing methodology.
Olink
Silver Sponsor
Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways.
Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base.
Parse Biosciences
Silver Sponsor
Parse Biosciences is a Seattle-based company with the mission of accelerating progress in human health and scientific research. At the core of our company is our pioneering approach for single cell sequencing. Single cell sequencing has already enabled groundbreaking discoveries which have led to new understandings of cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.
Sapient Bioanalytics
Silver Sponsor
Sapient is a leader in multi-omics discovery, providing bespoke services for proteomics, metabolomics, lipidomics data generation and delivering insights that enable biopharma sponsors to go beyond the genome to accelerate precision drug development.
Utilizing cutting-edge, high throughput mass spectrometry, we make nontargeted and targeted measurements to capture thousands of dynamic biomarkers – including proteins, metabolites, and lipids – per sample, across thousands of samples at a time. We pair this with advanced biocomputational frameworks enabling comprehensive biomarker-phenotype mapping and integrative analyses with other omics and real-world data.
Aided by our proprietary Human Biology Database — comprising data from tens of thousands of samples in which we can mine for and validate biomarkers and targets — we can support rapid drug target identification, biomarker discovery and validation, and translational insights across all stages of drug development, including clinical trials.
Scale Biosciences
Silver Sponsor
Scale Biosciences is at the forefront of a new era in single cell research, providing scientists with the tools they need to push the boundaries of biological discovery. Our innovative platforms combine accessibility, flexibility, and scalability, allowing researchers to design experiments that fit their unique scientific objectives without compromising on quality or results. By enabling the analysis of up to millions of cells and the multiplexing of hundreds of samples, Scale Bio empowers scientists to generate rich, comprehensive datasets that can unlock new insights into complex biological systems. We are dedicated to collaborating with the scientific community to drive innovation and accelerate breakthroughs in single cell-omics. Join Scale Bio on this transformative journey and help unleash the full potential of single cell research today.
Single Cell Discoveries
Silver Sponsor
Single Cell Discoveries is a Contract Research Organization (CRO) specializing in innovative single-cell sequencing technologies, multi-omic applications, and spatial transcriptomics. Single Cell Discoveries delivers high-impact insights to biopharmaceutical companies, healthcare systems, and academic research centers worldwide. Single Cell Discoveries' mission is to accelerate groundbreaking research by developing and providing state-of-the-art single-cell technologies as a service.
.jpg?length=600&name=a396bca6-7435-42de-8524-0ee4844b758e-2-5668375logo-standardbio-color-logo-blue-outline-blue-TM-(2).jpg){kind=logo}
Standard BioTools
Silver Sponsor
Standard BioTools™, previously known as Fluidigm®, is driven by a bold vision – Unleashing tools to accelerate breakthroughs in human health. Standard BioTools provides an established portfolio of essential, standardized technologies that empower customers to scale and accelerate their life sciences research. From interrogating cell function and cancer-immune cell interactions to confidently determining new biomarkers or integrity of samples, Standard BioTools promotes the development of breakthrough medicines faster and better through the delivery of consistent, reliable and repeatable results.
Bronze Sponsors
Aspect Analytics
Bronze Sponsor
Aspect Analytics develops enterprise software to analyze and integrate spatial omics data. Spatial technologies are steadily maturing into a key enabler in drug development, biomarker discovery, and life science research. With spatial omics datasets commonly generating tens to hundreds of gigabytes of complex data in a single experiment, data analysis is becoming a critical bottleneck in the adoption of this emerging technology. Aspect Analytics bridges the gap between algorithmic development in bioinformatics research and enterprise-grade software platforms to support key spatial omics-based applications. Our software can (i) extract maximal knowledge from spatial data, including co-registration with different modalities, (ii) scale up for high-throughput applications and (iii) provide integrated data management, traceability and more. Aspect Analytics enables breakthrough research and facilitates cross-disciplinary teamwork by bringing spatial multi-omics data into a single view, collaborative platform.
Atrandi Biosciences
Bronze Sponsor
Atrandi Biosciences is a pioneering life sciences tool company transforming single-cell analysis with Semi-Permeable Capsule (SPC) technology. SPCs redefine how single-cell research is done, enabling multi-step, high-throughput workflows while maintaining true single-cell resolution. Unlike conventional methods, SPCs allow researchers to perform multiomic assays seamlessly, unlocking deeper insights into biology. Founded by leading scientists and driven by a mission to simplify research and advance discovery, Atrandi is shaping the future of single-cell analysis and empowering scientists worldwide.
Beckman Coulter
Bronze Sponsor
We are a life sciences company that provides an extensive portfolio of solutions for workflow innovation, lab automation of routine tasks/complex methods, and software solutions to advance your research.
Our lab automation solutions and genomic reagents portfolio facilitate seamless processes for DNA/RNA clean-up, size selection, extraction, and sample preparation for NGS, RNA-seq, and single-cell transcriptomics. By integrating our advanced solutions into your lab, you can achieve high-quality, reproducible data, empowering your AI and machine learning models.
Becton Dickinson Biosciences
Bronze Sponsor
BD is a leading medical technology company that benefits countless lives worldwide. We advance health by improving the ways that discovery, diagnostics and delivery of care are conducted. With 45,000 employees at work in more than 50 countries, we work in close collaboration with customers and partners to develop innovative products and solutions that enhance outcomes, better manage healthcare delivery costs, increase efficiencies, improve healthcare safety, and expand access to health. Because we’ve been doing this for over 100 years, our portfolio, leadership and partnerships make a difference for global healthcare. For more information, please visit: www.bdbiosciences.com
CS Genetics
Bronze Sponsor
CS Genetics delivers simplicity in a world of complex, time-consuming and expensive single cell genomics workflows. Our nimble, experienced team understands that tomorrow’s discoveries require technology that is simple to adopt and easy to use with near-limitless scalability.
Our transformative new technology for single cell genomics replaces complex hardware and manual time-consuming workflows with a simple, instrument-free, solution-based, Kinetic Confinement assay that plugs seamlessly into any molecular biology laboratory. This simplicity also enables an affordable price point so researchers will no longer have to limit the scale of their studies.
.png?length=600&name=23c79081-69ce-4042-a188-0a0e10023652-2-5668375logo-Hawk-(RGB-Full-Colour).png)
Hawk Biosystems
Bronze Sponsor
HAWK Biosystems is an innovative biotechnology company based in Bilbao, Spain, and a spin-off from prestigious institutions such as Cancer Research UK (CRUK) and the Francis Crick Institute in London. Founded in 2018 by an exceptional team of scientists and business leaders, HAWK has rapidly positioned itself at the forefront of spatial biology, providing ground-breaking solutions for the analysis of protein functions in tissue.
At HAWK Biosystems, our mission is to develop advanced diagnostic systems that accelerate the progress of personalized medicine, focusing on critical diseases such as cancer. Our cutting-edge technology, QF-Pro®, is a revolutionary platform that enables precise, quantitative analysis of protein functions at a sub-pixel resolution. Unlike traditional techniques, QF-Pro® is capable of identifying protein-protein interactions and post-translational modifications within tissue samples at a resolution of less than 10 nanometers. This innovation provides clinicians and researchers with reproducible, robust, and unbiased data, which has demonstrated significant clinical value. For instance, QF-Pro® has been validated in a study to predict patient response to PD-1/PD-L1 inhibitors in lung cancer, demonstrating its potential to significantly improve treatment outcomes by potentially tripling response rates and doubling survival rates.
Leica Microsystems & Leica Biosystems
Bronze Sponsor
Leica Microsystems develops and manufactures microscopes and scientific instruments for
the analysis of microstructures and nanostructures. Widely recognized for optical precision
and innovative technology, the company is one of the market leaders in compound and stereo
microscopy, digital microscopy, confocal laser scanning and super-resolution microscopy.
Leica Biosystems (LeicaBiosystems.com) is a global leader in cancer diagnostics with the most comprehensive portfolio from biopsy to diagnosis. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.
Levitasbio
Bronze Sponsor
LevitasBio is dedicated to advancing science and
human health by providing researchers with new
and powerful methods for sample preparation and
characterization. The LeviCell platform is a
first-in-class cell enrichment solution powered
by a proprietary, label-free, and gentle Levitation
Technology. Our unique solution generates
high-quality samples while preserving the cells’
native state, enabling researchers across multiple
scientific disciplines to uncover true biology.
Accelerate Scientific Discovery With the Power of
Levitation Technology
RareCyte
Bronze Sponsor
RareCyte provides Precision Biology™ products and services for discovery, translational research and clinical diagnostics. The Orion™ spatial biology platform enables whole-slide highly multiplexed tissue analysis for multiple samples per day. Comprehensive liquid biopsy offerings enable CTC and other rare cell characterization and single cell retrieval for molecular analysis and CDx development.
.png?length=600&name=Zifo_Master%20Logo_Two%20colour_RGB%20(002).png)
Zifo Technologies
Bronze Sponsor
Zifo is a global specialist scientific and process informatics service provider working across research, development, manufacturing and clinical domains with expertise in over 90 partner technologies and platforms. We serve customers from Pharma/Biotech/CRO, Industrial chemicals and Food & Bev, to Consumer Goods and Oil and Gas. Our “Glocal” approach leverages remote delivery to ensure cost-effective delivery and solutions coupled with dedicated local support to ensure engagement, success and qualit
Network & Programme Sponsors
Aliri Bioanalysis
Network & Programme Sponsor
We provide a range of bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will help you advance your molecule from discovery through clinical development and NDA approval, while being backed by a network of technical experts and seasoned scientists.
.svg){kind=logo}
BioLizard
Network & Programme Sponsor
At BioLizard, we “think data” and “speak biology”, partnering with our clients to transform lives. Our expert team combines deep biological knowledge with cutting-edge AI and bioinformatics to tackle complex data challenges in human and animal health. Through our AI-native Bio|Verse platform, we accelerate biomarker discovery and enable actionable insights for modern drug development. With a global presence, we deliver tailored solutions in data management, bioinformatics, and AI to drive your data-driven strategy to biotech, pharma and diagnostic companies. Let’s shape the future of life sciences together—connect with BioLizard today!
.png?length=600&name=77f962ea-48c4-4469-ac13-19f7332176c0-2-5668375logo-DLS-Logo-FullColor-noTag-(4).png){kind=logo}
Discovery Life Sciences
Network & Programme Sponsor
Discovery Life Sciences is a global leader in biospecimens and specialty lab services, enabling the discovery and development of groundbreaking therapeutics and diagnostics. With a robust portfolio of human biospecimens and cellular starting material, preclinical ADME-tox solutions, and cutting-edge specialty lab services, we provide our partners with the tools, data and expertise they need to succeed. From genomics and proteomics to cell biology and molecular pathology, our comprehensive service offerings support every phase of the scientific journey, from research through clinical trials. For more information, visit www.dls.com.
.png?length=600&name=708bd68b-02d3-4436-8882-e6181f86f6da-2-5668375logo-Horizontal-Logo-(White-Background).png){kind=logo}
Elucidate Biotechnologies
Network & Programme Sponsor
Elucidate Bio provides multi-modal spatial biology services, enabling same-tissue imaging of DNA, RNA, and protein with single-cell spatial resolution. Powered by technology licensed from Sizun Jiang at Harvard Medical School/BIDMC, we specialize in single-slide spatial proteomic, transcriptomic, and genomic data
generation and analysis. With rigorous quality control, we deliver high-quality data, detailed analysis, and actionable insights to advance biomarker discovery, therapeutic development, and precision medicine. Contact Elucidate Bio to explore innovative spatial pipelines tailored to your program needs.
Psomagen
Network & Programme Sponsor
Psomagen, Inc., formerly Macrogen U.S.A., is a North American integrative omics solutions and contract laboratory services provider. The company makes cutting-edge technology and data analysis accessible to the academic, pharma, biotech and clinical markets. With both CLIA-certified and CAP-accredited facilities, its team delivers the highest-quality multiomics data using best-in-class DNA, RNA, and protein analysis systems. In conjunction with its bioinformatics capabilities, Psomagen offers a path to insights that is both simple and affordable. Learn more at psomagen.com.
Scailyte
Network & Programme Sponsor
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex molecular and cellular patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets.
Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (scRNA-seq, CITE-seq, CyTOF, TCR-/BCR-seq, etc.) with clinical endpoints, such as disease progression, severity, treatment response and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. Our discoveries elucidate drug MoA and inform on the risk benefit ratio.
The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in various clinical projects in immunology and oncology.
.png?length=600&name=ccf7bc56-af8b-49fe-b50e-b8bdf467ba91-2-5668375logo-StellaromicsLogo-(7).png)
Stellaromics
Network & Programme Sponsor
Stellaromics is dedicated to pioneering breakthroughs in 3D spatial multi-omics. The company's mission is to empower researchers with cutting-edge tools that illuminate the complexities of biological systems, enabling groundbreaking discoveries that improve human health.
The Stellaromics Pyxa platform enables researchers to visualize and analyze the spatial organization of cells and molecules within thick tissue samples at an unprecedented resolution. These breakthroughs, based on the company's STARmap and RIBOmap technologies, greatly expand upon applications of traditional 2D methods by offering a true 3D perspective, providing researchers with a deeper understanding of tissue organization, cellular interactions, and disease mechanisms.
Via Scientific
Network & Programme Sponsor
Via Scientific: AI-Powered Acceleration for Multi-Omics & Spatial Biology
AI-Driven Bioinformatics Innovation: Via Foundry, Via Scientific’s AI-powered platform, accelerates multi-omics research by eliminating bioinformatics bottlenecks. It enables research teams to build custom analysis pipelines without coding, automating data processing so scientists can focus on discovery. Foundry acts as a “force multiplier” for biomedical research, dramatically reducing time to insights.
Unified Multi-Omics & Spatial Insights: Designed for multi-omics and spatial biology, Via Foundry integrates genomics, transcriptomics, proteomics, and spatial data into a single platform. This fusion reveals deep biological insights missed by siloed analyses. With advanced visualization tools, Foundry handles large, complex datasets—accelerating discovery and development.
Empowering Next-Gen Research Collaboration: Built by scientists for scientists, Via Foundry upholds rigorous standards while enabling seamless collaboration across teams and long-term studies. With flexible deployment in the cloud or on-premises, it is trusted across academia, biotech, pharma, and healthcare. Combining AI-driven technology with an intuitive design, Via Scientific empowers researchers to unlock insights faster, more reliably, and at scale.
Visiopharm
Network & Programme Sponsor
Visiopharm® is a leading provider of AI-driven precision pathology software for research and diagnostics. In research, it is a technology leader providing tools that help scientists, pathologists, and image analysis experts produce accurate data for all types of tissue-based research. In diagnostics, it is a leader within clinical applications, with no less than eight diagnostic algorithms cleared under IVDR for EU and UK customers. These applications provide diagnostic decision support and can be easily activated and integrated into existing lab workflows.
Founded in 2002, Visiopharm is privately owned and operates internationally with over 750 customer accounts in more than 40 countries. The company's headquarters are located in Denmark's Medicon Valley, with legal entities in Sweden, the UK, Germany, the Netherlands, and the United States, and local representation in France and China.
Washington University
Network & Programme Sponsor
The McDonnell Genome Institute integrates cutting-edge ‘omics technologies and over 30 years of expertise to support your needs as your trusted partner. Explore our comprehensive solutions, including NGS, gene editing, stem cell biology, proteomics, and high-content imaging — custom-tailored to advance your research.
